The separation of substances that mediate or mimic the action of insulin could lead to develop of novel structures which may be of clinical use in the treatment of glucose metabolism abnormalities associated with T2DM and insulin resistance. The gene discussed is INS; the disease is type 2 diabetes mellitus.